297 related articles for article (PubMed ID: 31862264)
21. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.
Ateş A; Karaaslan Y; Aksaray S
Clin Rheumatol; 2007 Apr; 26(4):499-504. PubMed ID: 16670828
[TBL] [Abstract][Full Text] [Related]
22. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.
El-Banna H; Jiman-Fatani A
BMC Musculoskelet Disord; 2014 Nov; 15():379. PubMed ID: 25406539
[TBL] [Abstract][Full Text] [Related]
23. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
Maksymowych WP; Boire G; van Schaardenburg D; Wichuk S; Turk S; Boers M; Siminovitch KA; Bykerk V; Keystone E; Tak PP; van Kuijk AW; Landewé R; van der Heijde D; Murphy M; Marotta A
J Rheumatol; 2015 Sep; 42(9):1587-94. PubMed ID: 26178283
[TBL] [Abstract][Full Text] [Related]
24. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
25. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
26. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of detecting HLA-DR, 14-3-3η protein and d-dimer in the diagnosis of rheumatoid arthritis.
Tan L; Wang Q; Zeng T; Long T; Guan X; Wu S; Zheng W; Fu H; Meng Y; Wu Y; Tian Y; Yu J; Chen J; Li H; Cao L
Biomark Med; 2018 Jul; 12(7):697-705. PubMed ID: 29856230
[TBL] [Abstract][Full Text] [Related]
28. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
Heidari B; Firouzjahi A; Heidari P; Hajian K
Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
[TBL] [Abstract][Full Text] [Related]
29. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM
J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232
[TBL] [Abstract][Full Text] [Related]
30. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D
Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
33. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
[TBL] [Abstract][Full Text] [Related]
36. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
37. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
Ziegelasch M; van Delft MA; Wallin P; Skogh T; Magro-Checa C; Steup-Beekman GM; Trouw LA; Kastbom A; Sjöwall C
Arthritis Res Ther; 2016 Dec; 18(1):289. PubMed ID: 27912793
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of anti-Sa antibody and anti-carbamylated protein antibody for rheumatoid arthritis].
Lyu YK; Li ZA; A XR; Ma JD; Zhou JW; Wang LJ
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2947-2951. PubMed ID: 37752054
[No Abstract] [Full Text] [Related]
40. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]